SMTL ID : 4xrj.1

Crystal structure of ERK2 in complex with an inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.69 Å

Oligo State

monomer

Ligands

1 x 620: N~1~-[3-(benzyloxy)benzyl]-1H-tetrazole-1,5-diamine(Non-covalent)

620.1: 11 residues within 4Å: Chain A: A.42, I.43, K.44, E.61, I.62, I.93, Q.95, D.96, L.97, M.98, L.146 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:A.42, A:K.44, A:K.44, A:E.61, A:I.62, A:I.93, A:Q.95, A:Q.95 Hydrogen bonds: A:D.96, A:M.98 Water bridges: A:Q.95

1 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 3 residues within 4Å: Chain A: R.181, R.184, Y.223 2 PLIP interactions: 2 interactions with chain A Salt bridges: A:R.181, A:R.184

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Gelin, M. et al., Combining `dry' co-crystallization and in situ diffraction to facilitate ligand screening by X-ray crystallography. Acta Crystallogr.,Sect.D (2015)

Release Date

2015-08-12

Peptides

Mitogen-activated protein kinase 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Mitogen-activated protein kinase 1

Related Entries With Identical Sequence